Allergy Therapeutics PLC Stock
€0.088
Your prediction
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
Cons
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | - | -2.778% | 6.061% | 45.833% | 27.737% | -40.476% | -42.810% |
| Beximco Pharmaceuticals Ltd. GDR | 0.000% | 0.000% | -14.286% | 21.622% | 8.173% | -27.419% | -53.608% |
| SELLAS Life Sciences Group Inc | 5.710% | 8.809% | -18.758% | 15.000% | 41.764% | -46.725% | -49.220% |
| Eledon Pharmaceuticals Inc. | 2.330% | -10.204% | -55.705% | -62.921% | -67.647% | -45.902% | -91.698% |
News
3 Absurdly Cheap Dividend Stocks to Buy for Less Than $100
Buying dividend stocks at low prices can have two positive benefits. The first is that if you're buying low, the yield can be higher than normal. It can provide you with some high dividend income
Great News for AST SpaceMobile Investors
AST SpaceMobile (NASDAQ: ASTS) is on a mission to eliminate dead zones through direct-to-smartphone satellite technology. Its partnerships with telecom giants like AT&T and Vodafone and its massive
Is AT&T Stock a Buy?
AT&T (NYSE: T) is the third-largest wireless carrier in the U.S., serving over 90 million customers. Wireless generates the majority of the company's roughly $120 billion in annual revenue. AT&T


